Austin, TX-based Apollo Endosurgery, an early stage company developing devices for surgical procedures conducted through natural orifices, has secured $11.5 million in Series A financing. The round — participated in by PTV […]
Global Cancer Consortium
Imalux Closes $5.1 Million Series C Financing
Imalux, a Cleveland, OH-based firm specializing in imaging technology, has closed a Series C round of $5.1 million, including conversion of $2.5 million of bridge financing. The funding — for which lead […]
BioForce Nanosciences Completes Series A Financing
BioForce Nanosciences, an Ames, IA-based nanotechnology firm, has completed a $3.45 million Series A financing. The money will go toward expanded sales and marketing for the company’s flagship product, the Nano eNabler, […]
Vermillion Closes $20.6 Million Equity Financing
Vermillion (formerly Ciphergen Biosystems), a Fremont, CA-based molecular diagnostics firm, has closed a $20.6 million equity financing with new and existing investors. The financing, which comes two weeks after the company received […]
Pittsburgh Partnership Backs Three Up and Comers
The Pittsburgh Life Sciences Greenhouse (PLSG), a public/private partnership founded in 2001 to grow Southwestern Pennsylvania’s life sciences industry, has added two local companies — Separation Design Group and ThermalTherapeutics Systems — […]
DiagnoCure Acquires Cancer Tests for $3 Million
DiagnoCure, a Quebec City company that sells cancer diagnostics, has acquired Worcester, MA-based Catalyst Oncology and its lead prognostic tests for breast, colon and potentially other cancers. DiagnoCure, which will pay $3 […]
Three Pittsburgh Firms Split $350K
Pittsburgh Life Sciences Greenhouse (PLSG), a regional organization dedicated to nurturing startup life sciences companies in Southwestern Pennsylvania, has invested $350,000 in three local firms — Falcon Genomics, Glucose Sensing Technologies, and […]
GeneNews Secures $2 Million for Prostate Tests
GeneNews (formerly ChondroGene), a Toronto-based molecular diagnostics firm, has secured $2 million in funding through an agreement with an Asian Biomedical consortium. GeneNews’ most advanced product is ColonSentry — a non-invasive test […]
